Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2026
A phantom study to achieve comparable 124I PET recovery and address scanner variability for dosimetry purposes in (re)differentiated thyroid cancer.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dotinga Maaike, de Geus-Oei Lioe-Fee, Dibbets-Schneider Petra, Stam Mette K, Pool Martin, Pereira Arias-Bouda Lenka M, Kapiteijn Ellen, Vriens Dennis, van Velden Floris H P
Аннотация
BACKGROUND: Accurate quantification of iodine uptake is essential for performing pre-treatment dosimetry of 131I therapy after redifferentiation of radioiodine-refractory thyroid cancer. Standardized procedures for 124I PET/CT-based dosimetry are currently lacking. We aim to evaluate the relation between 18F and 124I imaging for two different PET/CT scanners, the effect of bias correction on recovery across scanners and investigate the impact of clinically-encountered background (BG)-to-lesion ratios on recovery correction.
METHODS: Cylindrical and NEMA body phantoms were scanned following vendor-recommended 124I acquisition using clinically representative activity concentrations (5.6-5.7 kBq/mL in cylindrical phantom, 45.1-59.2 kBq/mL in NEMA spheres) and BG-to-sphere ratios (∼1:125 to 1:infinity) using two digital PET/CT scanners (Philips Vereos and GE Healthcare Omni). Additionally, BG-to-sphere ratio ∼1:10 was acquired to compare 124I to the EARL 18F standards 1 (EARL1). Calibration accuracy and recovery coefficients (RCmax, RCmean) were compared between scanners with and without bias correction.
RESULTS: 124I recovery was ∼20% higher for the Omni compared to the Vereos, showing calibration accuracies of 1.12-1.15 vs. 0.94, and RCmean reaching 0.86 vs. 0.69. After bias correction, RCmean was comparable between scanners (<1%) but below the lower limits of EARL1. A single fit for recovery correction (R2 = 0.97) was obtained for different BG-to-sphere ratios for both scanners as RCmean was comparable (p > 0.4).
CONCLUSION: Vendor-recommended 124I acquisition and reconstruction leads to differences in quantification but can be compensated using a bias correction. Recovery correction is minimally affected by different BG-to-lesion ratios, suggesting that one RC curve is sufficient, simplifying 124I calibration procedures in studies requiring 124I quantification.
METHODS: Cylindrical and NEMA body phantoms were scanned following vendor-recommended 124I acquisition using clinically representative activity concentrations (5.6-5.7 kBq/mL in cylindrical phantom, 45.1-59.2 kBq/mL in NEMA spheres) and BG-to-sphere ratios (∼1:125 to 1:infinity) using two digital PET/CT scanners (Philips Vereos and GE Healthcare Omni). Additionally, BG-to-sphere ratio ∼1:10 was acquired to compare 124I to the EARL 18F standards 1 (EARL1). Calibration accuracy and recovery coefficients (RCmax, RCmean) were compared between scanners with and without bias correction.
RESULTS: 124I recovery was ∼20% higher for the Omni compared to the Vereos, showing calibration accuracies of 1.12-1.15 vs. 0.94, and RCmean reaching 0.86 vs. 0.69. After bias correction, RCmean was comparable between scanners (<1%) but below the lower limits of EARL1. A single fit for recovery correction (R2 = 0.97) was obtained for different BG-to-sphere ratios for both scanners as RCmean was comparable (p > 0.4).
CONCLUSION: Vendor-recommended 124I acquisition and reconstruction leads to differences in quantification but can be compensated using a bias correction. Recovery correction is minimally affected by different BG-to-lesion ratios, suggesting that one RC curve is sufficient, simplifying 124I calibration procedures in studies requiring 124I quantification.